Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rupolo

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Vox Sanguinis|February 20, 2008
Preclinical ex vivo expansion of peripheral blood CD34+ selected cells from cancer patients mobilized with combination chemotherapy and granulocyte colony-stimulating factorD Lorenzon, M Mazzucato, L Abbruzzese, et al.
Tumori|June 11, 1999
Gastric non-Hodgkin's lymphoma: analysis of 252 patients from a multicenter studyL Salvagno, M Sorarù, M Busetto, et al.
Biotherapy (Dordrecht, Netherlands)|May 20, 1998
Hodgkin's disease: a disorder of dysregulated cellular cross-talkA Pinto, V Gattei, V Zagonel, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 11, 2019
The German Hodgkin Study Group risk model is useful for Hodgkin lymphoma patients receiving radiotherapy after autologous stem cell transplantC Furlan, F Matrone, M Rupolo, et al.
Bone Marrow Transplantation|October 10, 2017
Early consolidation with high-dose therapy and autologous stem cell transplantation is a feasible and effective treatment option in HIV-associated non-Hodgkin lymphoma at high riskA Re, G Gini, M Rupolo, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Vox Sanguinis|February 20, 2008
Preclinical ex vivo expansion of peripheral blood CD34+ selected cells from cancer patients mobilized with combination chemotherapy and granulocyte colony-stimulating factorD Lorenzon, M Mazzucato, L Abbruzzese, et al.
Tumori|June 11, 1999
Gastric non-Hodgkin's lymphoma: analysis of 252 patients from a multicenter studyL Salvagno, M Sorarù, M Busetto, et al.
Biotherapy (Dordrecht, Netherlands)|May 20, 1998
Hodgkin's disease: a disorder of dysregulated cellular cross-talkA Pinto, V Gattei, V Zagonel, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 11, 2019
The German Hodgkin Study Group risk model is useful for Hodgkin lymphoma patients receiving radiotherapy after autologous stem cell transplantC Furlan, F Matrone, M Rupolo, et al.
Bone Marrow Transplantation|October 10, 2017
Early consolidation with high-dose therapy and autologous stem cell transplantation is a feasible and effective treatment option in HIV-associated non-Hodgkin lymphoma at high riskA Re, G Gini, M Rupolo, et al.
Pageof 3